Identifying appropriate questions for randomized clinical trials in hospitalized children
A newly published consensus statement outlines questions for RCTs ranked according to importance and feasibility.
Advise patients on nutrition and a balanced diet that supplements GLP-1
According to JPMorgan Research, the GLP-1 market is expected to exceed $100 billion by 2023, with total users in the U.S. predicted to reach 30 million.
Despite setbacks, Neuralink’s first brain implant patient remains positive
Elon Musk’s first human experiments with his computer brain device have revealed serious flaws, but the paralyzed subjects have little regret.
Walgreens Boots Alliance sells Sencora stake for $400 million
Walgreens Boots Alliance, Inc. announced that it has sold its shares in Cencora, Inc. pursuant to Cencora’s approximately $400 million share repurchase. As a result of the transaction, Walgreens Boots Alliance’s ownership of Cencora common stock has decreased from approximately 13% to approximately 12%.
LinkedIn’s Model N:
Check out part 3 of our video interview with Jesse Mendelsohn, Pharmaceutical Executive, who explains why deeper analytics on channel, tracking and chargeback data can help manufacturers make smarter provider and payer contracting decisions.
Check out part 1 and part 2 here:
Part 1️⃣:https://lnkd.in/davKm9zM
Part 2️⃣:https://lnkd.in/dZNJWhSp
Check out Part 3️⃣below:⬇️
#ModelN #RevenueOptimization #RevenueManagement #LifeSciences
Have news you’d like to share on Pharma Pulse? Contact Social Media Editor Miranda Schmalfuss.
